Currently Viewing:
Supplements Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Prim
Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
Girishanthy Krishnarajah, MPH, MBA/MS, PhD; Jee-Yeon K. Lehmann, PhD; Brian Ellman, MBA; Rachel H. Bhak, MS; Maral DerSarkissian, PhD; Deane Leader, Jr, PhD, MBA; Ann L. Bullinger, PharmD; and Mei
Currently Reading
Participating Faculty

Participating Faculty

Publishing Staff

Editorial & Production


Jeff D. Prescott, PharmD, RPh
Senior Vice President of Operations and Clinical Affairs

Ida Delmendo
Senior Clinical Projects Manager

Cindy Spielvogel
Clinical Projects Manager

Jessica Toye
Project Manager

Proofreaders
Griselda Demassey
Maggie Shaw

Associate Editor
Jeanne Linke

Sarah Anwar
Assistant Editor

Michael R. Page, PharmD, RPh
Clinical Editor

Julianne Costello
Designer

Sales & Marketing

Justin T. Gallagher
Associate Publisher

Sara Belanger
Director of Sales

Gabrielle Consola
Michael Costella
National Account Managers

Operations & Finance

Michael Pico
Vice President of Operations

Leah Babitz, CPA
Vice President of Finance

Kim Rotunno
Accountant

John Burke
Group Director, Circulation & Production

Corporate
Mike Hennessy, Sr
Chairman and CEO

Jack Lepping
Vice Chairman

Mike Hennessy, Jr
President

Neil Glasser, CPA/CFE
Chief Financial Officer

Warren Dardine
Chief Marketing Officer

Steve Ennen
Chief Digital Strategy Officer

Kerrie Keegan
Vice President of Editorial Services and Production

Jung Kim
Vice President, Digital Media

Jeff Brown 
Chief Creative Officer

Shari Lundenberg
Human Resource Director

Faculty
Rachel H. Bhak, MS
Senior Analyst
Analysis Group, Inc
Boston, Massachusetts

Ann L. Bullinger, PharmD
Director
Medical Therapeutic Area, Immunoglobulin
CSL Behring, LLC
King of Prussia, Pennsylvania

Maral DerSarkissian, PhD
Associate
Analysis Group, Inc
Boston, Massachusetts

Mei Sheng Duh, MPH, ScD
Managing Principal
Analysis Group, Inc
Boston, Massachusetts

Brian Ellman, MBA
Vice President
Analysis Group, Inc
Boston, Massachusetts

Girishanthy Krishnarajah, MPH, MBA/MS, PhD
Director
Health Economics and Reimbursement Strategy
CSL Behring, LLC
King of Prussia, Pennsylvania

Deane Leader, Jr, PhD, MBA
CSL Behring, LLC (at time of study)
King of Prussia, Pennsylvania

Jee-Yeon K. Lehmann, PhD
Manager
Analysis Group, Inc
Boston, Massachusetts

Faculty Disclosures
These faculty report relationships with the following organizations:

Rachel H. Bhak, MS; Maral DerSarkissian, PhD; Mei Sheng Duh, MPH, ScD; Brian Ellman, MBA; and Jee-Yeon K. Lehmann, PhD
Employment
Analysis Group, Inc

Ann L. Bullinger, PharmD
Employment
CSL Behring, LLC

Girishanthy Krishnarajah, MPH, MBA/MS, PhD
Paid advisory board
CSL Behring, LLC
Employment

CSL Behring, LLC
Stock ownership
CSL Behring, LLC; GSK

Deane Leader, Jr, PhD, MBA
Employment (at time of study)
CSL Behring, LLC
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up